573 related articles for article (PubMed ID: 18459180)
21. Chemotherapy is the cornerstone of the combined surgical treatment of lung cancer with synchronous brain metastases.
Girard N; Cottin V; Tronc F; Etienne-Mastroianni B; Thivolet-Bejui F; Honnorat J; Guyotat J; Souquet PJ; Cordier JF
Lung Cancer; 2006 Jul; 53(1):51-8. PubMed ID: 16730853
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcomes in extracranial tumor sites and unusual toxicities with concurrent whole brain radiation (WBRT) and Erlotinib treatment in patients with non-small cell lung cancer (NSCLC) with brain metastasis.
Olmez I; Donahue BR; Butler JS; Huang Y; Rubin P; Xu Y
Lung Cancer; 2010 Nov; 70(2):174-9. PubMed ID: 20207442
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life.
Spiro SG; Rudd RM; Souhami RL; Brown J; Fairlamb DJ; Gower NH; Maslove L; Milroy R; Napp V; Parmar MK; Peake MD; Stephens RJ; Thorpe H; Waller DA; West P;
Thorax; 2004 Oct; 59(10):828-36. PubMed ID: 15454647
[TBL] [Abstract][Full Text] [Related]
24. Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397).
Manon R; O'Neill A; Knisely J; Werner-Wasik M; Lazarus HM; Wagner H; Gilbert M; Mehta M;
J Clin Oncol; 2005 Dec; 23(34):8870-6. PubMed ID: 16314647
[TBL] [Abstract][Full Text] [Related]
25. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
[TBL] [Abstract][Full Text] [Related]
26. Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer.
Moon YW; Choi SH; Kim YT; Sohn JH; Chang J; Kim SK; Park MS; Chung KY; Lee HJ; Kim JH
Cancer; 2007 May; 109(9):1829-35. PubMed ID: 17366594
[TBL] [Abstract][Full Text] [Related]
27. Management of brain metastases.
Soffietti R; Rudā R; Mutani R
J Neurol; 2002 Oct; 249(10):1357-69. PubMed ID: 12382150
[TBL] [Abstract][Full Text] [Related]
28. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer.
Brown J; Thorpe H; Napp V; Fairlamb DJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG; Stephens RJ; Waller D; West P; Peake MD
J Clin Oncol; 2005 Oct; 23(30):7417-27. PubMed ID: 16157935
[TBL] [Abstract][Full Text] [Related]
29. Brain metastasis is an early manifestation of distant failure in stage III nonsmall cell lung cancer patients treated with radical chemoradiation therapy.
Germain F; Wai ES; Berthelet E; Truong PT; Lesperance M
Am J Clin Oncol; 2008 Dec; 31(6):561-6. PubMed ID: 19060588
[TBL] [Abstract][Full Text] [Related]
30. [Paclitaxel and cisplatin combined with etoposide chemotherapy in non-small cell lung cancer with brain metastases].
Yang QY; Chen LK; Xu GC; Liu JL; Liang Y; Zhang LN
Ai Zheng; 2004 Nov; 23(11 Suppl):1459-62. PubMed ID: 15566657
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
32. Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases.
Scott C; Suh J; Stea B; Nabid A; Hackman J
Am J Clin Oncol; 2007 Dec; 30(6):580-7. PubMed ID: 18091051
[TBL] [Abstract][Full Text] [Related]
33. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary resection in patients with nonsmall-cell lung cancer treated with gamma-knife radiosurgery for synchronous brain metastases.
Yang SY; Kim DG; Lee SH; Chung HT; Paek SH; Hyun Kim J; Jung HW; Han DH
Cancer; 2008 Apr; 112(8):1780-6. PubMed ID: 18300239
[TBL] [Abstract][Full Text] [Related]
35. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
[TBL] [Abstract][Full Text] [Related]
36. Brain metastases in breast cancer: prognostic factors and management.
Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
[TBL] [Abstract][Full Text] [Related]
37. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
38. Treatment of brain metastases from non-small-cell lung cancer (NSCLC): radiotherapy.
Zabel A; Debus J
Lung Cancer; 2004 Aug; 45 Suppl 2():S247-52. PubMed ID: 15552806
[TBL] [Abstract][Full Text] [Related]
39. Value of whole brain re-irradiation for brain metastases--single centre experience.
Sadikov E; Bezjak A; Yi QL; Wells W; Dawson L; Millar BA; Laperriere N
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):532-8. PubMed ID: 17662582
[TBL] [Abstract][Full Text] [Related]
40. Treatment of solitary brain metastasis. Resection followed by whole brain radiation therapy (WBRT) and a radiation boost to the metastatic site.
Rades D; Raabe A; Bajrovic A; Alberti W
Strahlenther Onkol; 2004 Mar; 180(3):144-7. PubMed ID: 14991201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
